Moreover, therapeutic lowering of SULF2 using antisense oligonucleotides reduced hypertriglyceridemia in db/db mice (88) and introduced a new therapeutic window for T2D-associated hyperlipidemia. The gene discussed is SULF2; the disease is type 2 diabetes mellitus.